To evaluate whether IFN-γ-induced epithelial MHCII expression protects against colitis we administered neutralizing anti-IFN-γ mAb to pIV+/− K14 CIITA Tg mice 11 days after initial anti-IL-10R treatment to avoid interference with T cell polarization. The gene discussed is KRT14; the disease is colitis.